tiprankstipranks

Barclay Phillips Insider Profile

4 Followers
Barclay Phillips, SVP, Chief Financial Officer at Novavax, holds 0.00 shares in G1 Therapeutics (Ticker: GTHX), holds 9.56K shares in Novavax (Ticker: NVAX), holds ― shares in Immunic (Ticker: IMUX).
tipranks
Barclay Phillips

Barclay Phillips
Novavax (NVAX)
SVP, Chief Financial Officer

Ranked #5,975 out of 98,909 Corporate Insiders

Profitable Transactions

100%
4 out of 4 Profitable Transactions

Average Return

+79.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$295K
53.37%
46.63%
0.00%
0.00%
A breakdown of Barclay Phillips's holdings

Insider Roles

Acorda Therapeutics
(ACORQ)
Director
Novavax
(NVAX)
SVP, Chief Financial Officer
G1 Therapeutics
(GTHX)
SVP & CFO
Immunic
(IMUX)
Director
Roles that Barclay Phillips holds in companies

Most Profitable Insider Trade

Stock:
Novavax
(NVAX)
Rating:Informative Buy
Date:Oct 06, 2014 - Oct 06, 2015
Return:+189.20%
The most profitable trade made by Barclay Phillips

Barclay Phillips's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Novavax
Aug 01, 2017
SVP, Chief Financial Officer
Uninformative Buy
1.83K
$137.62K
G1 Therapeutics
Nov 16, 2018
SVP & CFO
Uninformative Sell
199.55K
$0.00
Immunic
Director
Acorda Therapeutics
Director
$157.49K
List of latest transactions for each holding click on a transaction to see Barclay Phillips's performance on stock

Barclay Phillips insider profile FAQ

What is the percentage of profitable transactions made by Barclay Phillips?
The percentage of profitable transactions made by Barclay Phillips is 100%.
    What is the average return per transaction made by Barclay Phillips?
    The average return per transaction made by Barclay Phillips is 79.20%.
      What stocks does Barclay Phillips hold?
      Barclay Phillips holds: NVAX, GTHX, IMUX, ACORQ stocks.
        What was Barclay Phillips’s latest transaction?
        Barclay Phillips latest transaction was an Uninformative Sell of $199.55K.
          What was Barclay Phillips's most profitable transaction?
          Barclay Phillips’s most profitable transaction was an Informative Buy of NVAX stock on October 6, 2014. The return on the trade was 189.20%.
            What is Barclay Phillips's role in Novavax?
            Barclay Phillips's role in Novavax is SVP, Chief Financial Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.